Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
HALOZYME THERAPEUTICS, INC. (HALO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS"
07/27/2023 144 Form 144 - Report of proposed sale of securities:
07/26/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/18/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.3% stake in Halozyme Therapeutics Inc.
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS"
05/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/18/2023 144 Form 144 - Report of proposed sale of securities:
03/24/2023 ARS Form ARS - Annual Report to Security Holders:
03/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/13/2023 8-K Other Events  Interactive Data
02/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/10/2023 SC 13G/A BlackRock Inc. reports a 14.2% stake in HALOZYME THERAPEUTICS INC
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.8% stake in Halozyme Therapeutics Inc.
02/06/2023 8-K Quarterly results
01/26/2023 SC 13G/A BlackRock Inc. reports a 13.6% stake in HALOZYME THERAPEUTICS INC
01/20/2023 SC 13G BlackRock Inc. reports a 13.6% stake in HALOZYME THERAPEUTICS INC
01/10/2023 8-K Quarterly results
12/12/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
08/19/2022 8-K Quarterly results
08/18/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy